Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Zevia PBC (ZVIA) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Beverages - Non-Alcoholic
$1.29
-0.01 (-0.39%)Did ZVIA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Zevia is one of their latest high-conviction picks.
Based on our analysis of 8 Wall Street analysts, ZVIA has a bullish consensus with a median price target of $5.00 (ranging from $1.75 to $6.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $1.29, the median forecast implies a 289.1% upside. This outlook is supported by 5 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Sarang Vora at Telsey Advisory Group, projecting a 366.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ZVIA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 26, 2026 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $5.00 |
| Jan 14, 2026 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $6.00 |
| Nov 6, 2025 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $6.00 |
| Oct 29, 2025 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $6.00 |
| Aug 14, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Aug 12, 2025 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $2.70 |
| Aug 7, 2025 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $6.00 |
| Aug 7, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Aug 4, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Upgrade | $5.00 |
| May 8, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| May 5, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| Feb 27, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| Jan 14, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $4.00 |
| Jan 14, 2025 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $3.75 |
| Nov 7, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| Nov 4, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| May 9, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| May 9, 2024 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $1.00 |
| May 9, 2024 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $1.25 |
| Feb 28, 2024 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $2.00 |
The following stocks are similar to Zevia based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces zero-calorie, naturally sweetened beverages.
Zevia PBC generates revenue by offering a diverse range of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily sweetened with stevia. The company targets health-conscious consumers seeking healthier alternatives to sugary drinks, which allows it to capture a growing market segment focused on wellness and sustainability.
Based in Los Angeles, Zevia emphasizes non-GMO, vegan, and gluten-free products, positioning itself favorably within the non-alcoholic beverage industry. Its commitment to clean-label offerings and health trends has led to increased distribution in supermarkets and health food stores across North America, aligning with the rising consumer demand for health-oriented products.
Consumer Defensive
Beverages - Non-Alcoholic
91
Ms. Amy E. Taylor
United States
2021
Zevia PBC (ZVIA) held its Q4 2025 earnings call, discussing financial performance and future outlook. Key insights from the call are vital for investor considerations.
Zevia's Q4 2025 earnings call provides insights into financial performance, growth potential, and strategic direction, critical for assessing investment value and market competitiveness.
Zevia PBC (NYSE: ZVIA) reported Q4 2025 net sales of $37.9 million, down $1.6 million year-over-year. Gross profit margin decreased to 47.7%.
Zevia's declining net sales and gross profit margin may signal challenges in growth and profitability, affecting investor confidence and stock performance.
Zevia PBC (NYSE:ZVIA) will release its Q4 and full year financial results on February 25, 2026, after market close, followed by a conference call at 4:30 PM ET.
Zevia's upcoming financial results announcement could influence stock performance and investor sentiment, providing insights into its growth and market strategy in the competitive beverage sector.
The consumer staples sector has identified several oversold stocks, indicating potential investment opportunities in undervalued companies.
Oversold consumer staples stocks indicate potential undervaluation, offering investors opportunities for gains as prices may rebound.
Zevia PBC (NYSE: ZVIA) appointed Suzanne Ginestro, CMO of Califia Farms, to its Board of Directors and Compensation Committee, enhancing board diversity with her 25+ years of marketing experience.
Zevia's board diversification with Suzanne Ginestro enhances its marketing leadership, potentially improving brand strategy and growth, which can positively impact investor confidence and stock performance.
Zevia, a high-growth beverage company, reports double-digit revenue growth and strong distribution but remains unprofitable due to high marketing costs. It has $26M in cash and a $20M credit line.
Zevia's strong revenue growth and distribution expansion signal potential for future profitability, while a solid balance sheet reduces dilution risk, making it an attractive prospect for investors.
Based on our analysis of 8 Wall Street analysts, Zevia PBC (ZVIA) has a median price target of $5.00. The highest price target is $6.00 and the lowest is $1.75.
According to current analyst ratings, ZVIA has 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.29. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ZVIA stock could reach $5.00 in the next 12 months. This represents a 289.1% increase from the current price of $1.29. Please note that this is a projection by Wall Street analysts and not a guarantee.
Zevia PBC generates revenue by offering a diverse range of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily sweetened with stevia. The company targets health-conscious consumers seeking healthier alternatives to sugary drinks, which allows it to capture a growing market segment focused on wellness and sustainability.
The highest price target for ZVIA is $6.00 from Sarang Vora at Telsey Advisory Group, which represents a 366.9% increase from the current price of $1.29.
The lowest price target for ZVIA is $1.75 from at , which represents a 36.2% increase from the current price of $1.29.
The overall analyst consensus for ZVIA is bullish. Out of 8 Wall Street analysts, 5 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $5.00.
Stock price projections, including those for Zevia PBC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.